Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VPS16 functions as a core structural subunit of both the CORVET and HOPS multi-protein complexes, which mediate tethering and fusion of endosomal and lysosomal membranes[6][1][2][5]. VPS16 binds specifically to VPS33A, facilitating the recruitment of SNARE protein complexes and regulating vesicle fusion events critical for endocytic and autophagic trafficking[6][5][2][3]. Defects in VPS16 (mutations or reduced expression) result in impaired endosome and lysosome fusion, causing cellular trafficking defects and disease phenotypes similar to lysosomal storage disorders[7]. VPS16 itself is not a receptor, enzyme, transporter, or transcription factor, but is an essential adaptor and organizer within these trafficking complexes[6][1][2][7]. In summary: VPS16 is crucial as an organizing scaffold for membrane fusion in the endolysosomal system, working within the CORVET and HOPS complexes as a structural trafficking protein, not as a classical direct drug target[6][1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 16 homolog (VPS16).